Skip to main content
Equibles
HNGE logo

HNGE · Hinge Health, Inc. · Metrics

Track HNGE — free

Use HNGE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HNGE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$96.57 -0.67 (-0.69%)
Russell 2000 member Rebalance outlook locked
Market Cap
$7.71B
Shares
80.69M
Volume · Oct 1 1.42M Avg daily vol (3M) 1.79M

HNGE metrics

69 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$97.24
Market cap
$7.71B

Price action

20 metrics
Price change (1W)
+5.4%
Price change (30D)
+8.0%
Price change (3M)
+14.3%
Price change (6M)
+152.6%
Price change (YTD)
+109.3%
Price change (1Y)
+98.1%
Trailing year
Price change (5Y)
—
52-week high
$97.24
52-week low
$31.17
Change from 52-week high
+0.0%
Change from 52-week low
+212.0%
Annualized volatility
54.4%
Annualized volatility (3M)
47.1%
Beta
1.0
RSI (14D)
60.6
Price vs SMA 50
+10.9%
Price vs SMA 200
+60.3%
Avg volume (3M)
1.79M
Relative volume
0.9
Average dollar volume
$157.20M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
80.69M

Valuation

12 metrics
P / E (TTM)
19.6
Trailing earnings · reciprocal yield 5.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
10.7×
reciprocal yield 9.3%
P / book
22.4
reciprocal yield 4.5%
FCF yield
3.8%
TTM · current market cap
Buyback yield
2.5%
P / FCF
26.6
reciprocal yield 3.8%
P / operating cash flow
26.5
reciprocal yield 3.8%
Earnings yield
1.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
84.5%
Operating margin
13.0%
Trailing 12 months
Net margin
15.1%
Gross profit (TTM)
$608.41M
Operating profit (TTM)
$93.67M
Net income (TTM)
$109.07M
Trailing 12 months
Diluted EPS (TTM)
$4.95
FCF margin
40.3%
Effective tax rate
1.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-26.53

Growth

11 metrics
Revenue growth YoY
+53.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$720.06M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+89.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
31.7%
Return on assets
13.2%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
$98.39M
Free cash flow (TTM)
$290.12M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$286.22M
Total assets
$827.40M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$290.79M
Capital expenditures (TTM)
$666,000
R&D (TTM)
$129.07M
SG&A (TTM)
—
Stock compensation (TTM)
$82.80M
R&D / revenue
17.9%
Stock compensation / revenue
11.5%

Ownership (13F)

3 metrics
13F filers
279
13F filer change QoQ
+75
Institutional ownership
73.8%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$108.12M
Insider-sentiment score
47 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1673743 CUSIP 433313103 13F (30d) 8 filings 8 filers Visit website Investor relations